The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Mon., Apr. 12, 6:35 PM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #78. Quest Diagnostics Solstas Lab Partners

Acquirer: Quest Diagnostics (NYSE:DGX)
Acquiree: Solstas Lab Partners
Details: Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has completed the previously announced acquisition of Solstas Lab Partners Group and its subsidiaries (Solstas), a full-service commercial laboratory company based in Greensboro, North Carolina. The combination of Solstas with Quest Diagnostics will give patients and healthcare providers in the Southeastern United States, where Solstas operates in nine states, including the Carolinas, Virginia, Tennessee, Georgia and Alabama, greater access to innovative and cost-effective diagnostic information services.

Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.

Quest Diagnostics SEC Filing Email Alerts Service


Open the DGX Page at The Online Investor »

Company Name: 
Quest Diagnostics, Inc.
Stock buyback: 
DGX buyback
Website: 
www.QuestDiagnostics.com
Sector: 
Diagnostics
Number of ETFs Holding DGX: 
109
Total Market Value Held by ETFs: 
$2.67B
Total Market Capitalization: 
$16.90B
% of Market Cap. Held by ETFs: 
15.80%
 

Open the DGX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (3.08 out of 4)
34th percentile
(ranked lower than approx. 66% of all stocks covered)

Analysts' Target Price:
DGX Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 78 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.